Dogwood Therapeutics, Inc. (DWTX)
NASDAQ: DWTX · Real-Time Price · USD
1.650
0.00 (0.00%)
Jun 29, 2026, 9:32 AM EDT - Market open
Dogwood Therapeutics Market Cap
Dogwood Therapeutics has a market cap or net worth of $55.49 million as of June 29, 2026. Its market cap has increased by 460.51% in one year.
Market Cap
55.49M
Enterprise Value
42.41M
1-Year Change
460.51%
Ranking
Category
Stock Price
$1.65
Market Cap Chart
Since December 17, 2020, Dogwood Therapeutics's market cap has decreased from $130.88M to $55.49M, a decrease of -57.60%. That is a compound annual growth rate of -14.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 29, 2026 | 55.49M | -55.13% |
| Dec 31, 2025 | 123.67M | 3,628.17% |
| Dec 31, 2024 | 3.32M | -70.04% |
| Dec 29, 2023 | 11.07M | 155.97% |
| Dec 30, 2022 | 4.33M | -89.85% |
| Dec 31, 2021 | 42.61M | -27.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veraxa Biotech AG | 58.50M |
| MiNK Therapeutics | 57.99M |
| Filana Therapeutics | 57.97M |
| Boundless Bio | 57.50M |
| Xilio Therapeutics | 54.14M |
| Context Therapeutics | 53.29M |
| aTyr Pharma | 51.72M |
| Impact BioMedical | 50.78M |